Related references
Note: Only part of the references are listed.Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke
Maarten Uyttenboogaart et al.
ARCHIVES OF NEUROLOGY (2008)
Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis
Yolanda Bravo et al.
CEREBROVASCULAR DISEASES (2008)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST)
Nils Wahlgren et al.
STROKE (2008)
Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke
Maarten G. Lansberg et al.
STROKE (2007)
Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Nils Wahlgren et al.
LANCET (2007)
Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials
Joan Marti-Fabregas et al.
CEREBROVASCULAR DISEASES (2007)
Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke
P Trouillas et al.
STROKE (2006)
Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke
S Schmulling et al.
CEREBROVASCULAR DISEASES (2003)
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice The multicenter rt-PA acute stroke survey
D Tanne et al.
CIRCULATION (2002)
Share Paper
